TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15045534

Group type: EXPERIMENTAL
Intervention: Supplementary standardized tape hypnosis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard treatment (only local anesthesia)
Number of subjects: 50
Study: 11523668

Group type: EXPERIMENTAL
Intervention: Stereotactic implantation of human neuronal cells
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: FDG PET
Number of subjects: 12
Study: 9933837

Group type: EXPERIMENTAL
Intervention: TURP (Transurethral Prostatic Resection)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: TULP (Transurethral Laser Prostatectomy)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (20 patients with bladder cancer undergoing transurethral resection and laser ablation)
Number of subjects: 57
Study: 7925207

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg kg‐1 immediately prior to thiopentone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Rocuronium 0.6 mg kg‐1 immediately after thiopentone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.04 mg kg‐1 prior to induction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Suxamethonium 1.5 mg kg‐1 immediately after thiopentone
Number of subjects: 80
Study: 3045451

Group type: EXPERIMENTAL
Intervention: Empiric antibiotic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open lung biopsy
Number of subjects: 0
Study: 29479070

Group type: EXPERIMENTAL
Intervention: Major molecular remission (MMR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1% BCR-ABL response
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deep molecular remission
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early achievement of MMR
Number of subjects: 0
Study: 27759808

Group type: EXPERIMENTAL
Intervention: Maintenance modified electroconvulsive therapy (MECT) combined with risperidone
Number of subjects: 62

Group type: COMPARATOR
Intervention: Risperidone only
Number of subjects: 62
Study: 25662558

Group type: EXPERIMENTAL
Intervention: Deep dry needling (DDN) of trigger points in the lateral pterygoid muscle
Number of subjects: 48

Group type: COMPARATOR
Intervention: Methocarbamol/paracetamol combination treatment
Number of subjects: 48
Study: 23098887

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (educational programme encouraging physical activity and healthy nutrition, provision of bicycles)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control
Number of subjects: 173
Study: 22087616

Group type: EXPERIMENTAL
Intervention: Massage therapy (20-minute massage by parents at home before bedtime every night for 5 weeks, in addition to standard asthma treatment)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (standard asthma treatment alone for 5 weeks)
Number of subjects: 60
Study: 18215682

Group type: EXPERIMENTAL
Intervention: Diaket and MTA
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: AH Plus and MTA
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Diaket and amalgam
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: AH Plus and amalgam
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Ketac Endo and MTA
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Ketac Endo and amalgam
Number of subjects: 108

Group type: COMPARATOR
Intervention: MTA
Number of subjects: 108
Study: 16638253

Group type: EXPERIMENTAL
Intervention: H. pylori serology testing
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no H. pylori testing)
Number of subjects: 47
Study: 14673051

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 3597

Group type: EXPERIMENTAL
Intervention: Itraconazole cyclodextrine solution
Number of subjects: 3597

Group type: EXPERIMENTAL
Intervention: Itraconazole capsules
Number of subjects: 3597

Group type: COMPARATOR
Intervention: Control without cyclodextrine
Number of subjects: 3597

Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 3597

Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 3597
Study: 10817039

Group type: EXPERIMENTAL
Intervention: Iopromide (n = 16; median volume 102 ml; 95% confidence interval 90‐108 ml)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Ioxaglate (n = 15; median volume 105 ml; 95% confidence interval 95‐114 ml)
Number of subjects: 31
Study: 9179339

Group type: EXPERIMENTAL
Intervention: Nutrition education program
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no nutrition education)
Number of subjects: 72
Study: 1556414

Group type: EXPERIMENTAL
Intervention: Sucralfate, 2 g b.i.d.
Number of subjects: 55

Group type: COMPARATOR
Intervention: Ranitidine, 150 mg b.i.d.
Number of subjects: 55
Study: 3932570

Group type: EXPERIMENTAL
Intervention: Proluton, 50‐mg daily injections given on days 7‐16 following oocyte recovery
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 186
Study: 31838377

Group type: EXPERIMENTAL
Intervention: Sodium selenite (SS) 400 μg elemental Se, taken orally daily for 8 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Se‐methylselenocysteine (MSC) 400 μg elemental Se, taken orally daily for 8 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Seleno‐l‐methionine (SLM) 400 μg elemental Se, taken orally daily for 8 weeks
Number of subjects: 24
Study: 31113455

Group type: EXPERIMENTAL
Intervention: LBEC0101 (50 mg) administered subcutaneously once per week for 48 weeks
Number of subjects: 148
Study: 27776217

Group type: EXPERIMENTAL
Intervention: Lepicol (pysllium fibre, inulin and 5 probiotic strains)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 25602128

Group type: EXPERIMENTAL
Intervention: FDIS+MET
Number of subjects: 184

Group type: COMPARATOR
Intervention: FDIS+placebo
Number of subjects: 184

Group type: COMPARATOR
Intervention: SRP+MET
Number of subjects: 184

Group type: COMPARATOR
Intervention: SRP+placebo
Number of subjects: 184
Study: 23723446

Group type: EXPERIMENTAL
Intervention: Closed-loop stimulation (CLS) algorithm ON
Number of subjects: 50

Group type: COMPARATOR
Intervention: Closed-loop stimulation (CLS) algorithm OFF
Number of subjects: 50
Study: 21843000

Group type: EXPERIMENTAL
Intervention: Implicit believability in health condition
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Implicit believability in appearance condition
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Explicit believability in health condition
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Thought-listing valence index in both conditions
Number of subjects: 306
Study: 18953265

Group type: EXPERIMENTAL
Intervention: bucindolol
Number of subjects: 309

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 309
Study: 18182867

Group type: EXPERIMENTAL
Intervention: Skin Surface Warming (SSW)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intravenous Fluid Warming (IFW)
Number of subjects: 60
Study: 12557133

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg daily
Number of subjects: 8076

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily
Number of subjects: 8076
Study: 18425649

Group type: EXPERIMENTAL
Intervention: Motivational approach
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Cognitive approach
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 150
Study: 8778866

Group type: EXPERIMENTAL
Intervention: Caffeine (400 mg) during a nap
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo during a nap
Number of subjects: 12
Study: 1873773

Group type: EXPERIMENTAL
Intervention: Bolus doxorubicin (60 mg/m2 every 3 to 4 weeks)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Continuous infusion doxorubicin (60 mg/m2 every 3 to 4 weeks)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Bolus doxorubicin
Number of subjects: 82

Group type: COMPARATOR
Intervention: Continuous infusion doxorubicin
Number of subjects: 82
Study: 6131529

Group type: EXPERIMENTAL
Intervention: Calcitonin
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Beta-blocking agents
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Griseofulvin
Number of subjects: 55
Study: 6729548

Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg by mouth b.i.d. X 30 doses)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Breast binders
Number of subjects: 50
Study: 28752937

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behaviour therapy (ICBT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Traditional logistic regression
Number of subjects: 61
Study: 26813033

Group type: EXPERIMENTAL
Intervention: Quality of Life Therapy (QOLT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Heart Healthy Education
Number of subjects: 60
Study: 23893353

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 25
Study: 22365864

Group type: EXPERIMENTAL
Intervention: Box training with additional practice (Group 3)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Mental training (Group 5)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: VRS training (Group 4)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Box training (Group 2 and 3)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Box training (Group 3)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (Group 1)
Number of subjects: 41
Study: 20507655

Group type: EXPERIMENTAL
Intervention: Educational and psychological intervention
Number of subjects: 374
Study: 18499368

Group type: EXPERIMENTAL
Intervention: Resistance training (RT), n=22, 16 weeks duration, 60-80% 1RM
Number of subjects: 43

Group type: COMPARATOR
Intervention: Not trained control (CT), n=21
Number of subjects: 43
Study: 15623816

Group type: EXPERIMENTAL
Intervention: GHRH (1 mg sc twice a day over 12 wk)
Number of subjects: 31
Study: 12925474

Group type: EXPERIMENTAL
Intervention: Combination of propacetamol 30 mg kg(‐1) and diclofenac 1.1 mg kg(‐1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Diclofenac 1.1 mg kg(‐1) alone
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cold pressor test
Number of subjects: 10
Study: 10822120

Group type: EXPERIMENTAL
Intervention: leaflet
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: brochure
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: booklet
Number of subjects: 415

Group type: COMPARATOR
Intervention: control
Number of subjects: 415
Study: 8630955

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MEG) 160 mg daily
Number of subjects: 266

Group type: COMPARATOR
Intervention: Premarin (PRE) 1.25 mg/day for the first 3 days of a 14 day cycle followed by Megestrol acetate (PRE/MEG)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MEG)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Premarin and Megestrol acetate (PRE/MEG)
Number of subjects: 266
Study: 1737157

Group type: EXPERIMENTAL
Intervention: Omeprazole 80 mg intravenously immediately, then three doses of 40 mg intravenously at eight hourly intervals, then 40 mg orally at 12 hourly intervals for four days
Number of subjects: 1147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1147
Study: 6884411

Group type: EXPERIMENTAL
Intervention: Sulphinpyrazone 800 mg daily
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 31642690

Group type: EXPERIMENTAL
Intervention: Vorapaxar
Number of subjects: 20138
Study: 30229370

Group type: EXPERIMENTAL
Intervention: General anesthesia with opioid analgesia (GA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Propofol-paravertebral anesthetic with continuing analgesia (PPA)
Number of subjects: 20
Study: 26551216

Group type: EXPERIMENTAL
Intervention: Empowerment support group (n = 56)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Comparison group (n = 66)
Number of subjects: 122
Study: 24732311

Group type: EXPERIMENTAL
Intervention: MnSOD transcript level in patients with diabetes (both with and without microvascular complications)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: MnSOD protein level in patients without microvascular complications
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Correlation of MnSOD expression with fasting plasma glucose and total cholesterol levels
Number of subjects: 46
Study: 21960371

Group type: COMPARATOR
Intervention: Stented group
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Non-stented group
Number of subjects: 156
Study: 20472045

Group type: EXPERIMENTAL
Intervention: Low-frequency ultrasound (US) applied during 5 min with a 36 kHz probe, pulsed mode (2s on/5s off), intensity of 2.72 W/cm², with betamethasone 17-valerate cream, 2-hour occlusion.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Topical steroids with 1-hour occlusion.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Massage alone (control group).
Number of subjects: 15

Group type: COMPARATOR
Intervention: Topical steroids with 2-hour occlusion (without US).
Number of subjects: 15
Study: 18630537

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with massage of sole and oral administration of Alprazolam
Number of subjects: 58

Group type: COMPARATOR
Intervention: Alprazolam (control group)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with massage of sole
Number of subjects: 58
Study: 16049630

Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Low-intensity resistance/flexibility training
Number of subjects: 174
Study: 11813825

Group type: EXPERIMENTAL
Intervention: Enhanced External Counterpulsation (EECP) therapy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Sham treatment (inactive-CP)
Number of subjects: 71
Study: 10379017

Group type: EXPERIMENTAL
Intervention: Systemic glucocorticoids (8-week course)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Systemic glucocorticoids (2-week course)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Systemic glucocorticoids (combined groups)
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Systemic glucocorticoids
Number of subjects: 271
Study: 7554626

Group type: EXPERIMENTAL
Intervention: Cemented femoral component
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncemented femoral component
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (1000 units)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cemented and noncemented femoral components
Number of subjects: 0
Study: 1940960

Group type: EXPERIMENTAL
Intervention: CDP‐choline
Number of subjects: 216

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 216
Study: 7104168

Group type: EXPERIMENTAL
Intervention: Nitrazepam 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Chlormezanone 400 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Neither drug
Number of subjects: 12
Study: 31388638

Group type: EXPERIMENTAL
Intervention: Transanal irrigation (TAI)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Supportive therapy (control)
Number of subjects: 37
Study: 28188240

Group type: EXPERIMENTAL
Intervention: Lixisenatide 20 μg once daily before breakfast for 24 weeks
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Lixisenatide
Number of subjects: 350
Study: 25694153

Group type: EXPERIMENTAL
Intervention: Posterior scleral reinforcement (PSR) combined with patching therapy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Posterior scleral reinforcement (PSR)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (contact lens wear and patching)
Number of subjects: 32
Study: 23797498

Group type: EXPERIMENTAL
Intervention: Lumbar spinous process splitting decompression (LSPSD)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Conventional midline decompression
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 51
Study: 20945253

Group type: EXPERIMENTAL
Intervention: 6-month group-based diabetes prevention programme (The Healthy Living Course)
Number of subjects: 307

Group type: COMPARATOR
Intervention: Waiting control group (standard care from GPs)
Number of subjects: 307
Study: 19145002

Group type: EXPERIMENTAL
Intervention: Low-sodium PD fluid with [Na+] = 115 mmol/l (group A)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Low-sodium PD fluid with [Na+] = 102 mmol/l (group B)
Number of subjects: 25
Study: 16887727

Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine treatment
Number of subjects: 150

Group type: COMPARATOR
Intervention: Previous audiometric studies
Number of subjects: 150
Study: 15253711

Group type: EXPERIMENTAL
Intervention: Amino acid infusion in ESRD patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amino acid infusion in healthy controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postabsorptive state in ESRD patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postabsorptive state in healthy controls
Number of subjects: 0
Study: 11517199

Group type: EXPERIMENTAL
Intervention: Infant Flow Driver (IFD)
Number of subjects: 36
Study: 9052418

Group type: EXPERIMENTAL
Intervention: Clodronate (1600 mg daily) with antioestrogens
Number of subjects: 121

Group type: COMPARATOR
Intervention: Antioestrogens only (20 mg tamoxifen or 60 mg toremifene daily)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 121

Group type: COMPARATOR
Intervention: Toremifene
Number of subjects: 121
Study: 7689752

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) infusion during OLT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no PGE1 infusion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups (PGE1 and control)
Number of subjects: 0
Study: 3518529

Group type: EXPERIMENTAL
Intervention: extract adsorbed to aluminium hydroxide (Alutard‐SQ)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pharmalgen extract
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: non‐adsorbed extract from Allergologisk Laboratorium (ALK aq.)
Number of subjects: 32

Group type: COMPARATOR
Intervention: All three extracts
Number of subjects: 32
Study: 28856945

Group type: EXPERIMENTAL
Intervention: Off-the-shelf ankle-foot orthosis
Number of subjects: 139

Group type: COMPARATOR
Intervention: Bespoke ankle-foot orthosis
Number of subjects: 139
Study: 27020594

Group type: EXPERIMENTAL
Intervention: Propofol (3-5 mg/kg i.v.)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sevoflurane (8% inhaled)
Number of subjects: 50
Study: 25590336

Group type: EXPERIMENTAL
Intervention: GET.ON Recovery (internet-based recovery training)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Waitlist-control (WLC)
Number of subjects: 128
Study: 23318391

Group type: EXPERIMENTAL
Intervention: CG-Darc
Number of subjects: 35
Study: 21320338

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic Q-potencies
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study: 19634966

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for insomnia
Number of subjects: 57
Study: 17244597

Group type: EXPERIMENTAL
Intervention: Olfactory function tests in farm workers
Number of subjects: 120

Group type: COMPARATOR
Intervention: Olfactory function tests in non-farm controls
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Olfactory function tests after first day of working cycle
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Olfactory function tests on Day 5 for farm subjects
Number of subjects: 120
Study: 15651516

Group type: EXPERIMENTAL
Intervention: 2 ml fentanyl
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 10 mg ketamine
Number of subjects: 150

Group type: COMPARATOR
Intervention: 2 ml normal saline (placebo)
Number of subjects: 150
Study: 11705075

Group type: EXPERIMENTAL
Intervention: Pentaglobin (5 ml/kg/day for 3 days)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (no immunoglobulins)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pentaglobin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Pentaglobin and Control
Number of subjects: 39
Study: 9156146

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids
Number of subjects: 0
Study: 7705155

Group type: EXPERIMENTAL
Intervention: Rate-adaptive pacing
Number of subjects: 30

Group type: COMPARATOR
Intervention: Fixed-rate pacing
Number of subjects: 30
Study: 2655491

Group type: EXPERIMENTAL
Intervention: Conjuvac injections (11 weekly injections of increasing concentrations from 56 x 10(1) to 448 10(3) IU D. pteronyssinus)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo injections (alginate diluent with some containing 5 micrograms of histamine)
Number of subjects: 66
Study: 921867

Group type: EXPERIMENTAL
Intervention: 4% lignocaine with a radio-opaque substance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Caudal extradural blocks with different local anaesthetic agents
Number of subjects: 0
Study: 31883621

Group type: EXPERIMENTAL
Intervention: M‐Wire Reciproc
Number of subjects: 26

Group type: COMPARATOR
Intervention: Reciproc Blue
Number of subjects: 26
Study: 31489422

Group type: EXPERIMENTAL
Intervention: HCQ+modified Xiaoyao pill
Number of subjects: 60

Group type: COMPARATOR
Intervention: HCQ
Number of subjects: 60
Study: 28387540

Group type: EXPERIMENTAL
Intervention: n-3 FA supplementation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 25499599

Group type: EXPERIMENTAL
Intervention: Early physiotherapy intervention combined with a therapeutic education program (n=76)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Therapeutic education program only (control group, n=77)
Number of subjects: 153
Study: 25574800

Group type: EXPERIMENTAL
Intervention: Propofol at an effect-site concentration of 2.5 µg/mL combined with remifentanil (0.25 to 0.35 μg/kg/min) and cisatracurium (0.03 to 0.04 mg/kg/h)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sevoflurane at 0.5 MAC combined with remifentanil (0.25 to 0.35 μg/kg/min) and cisatracurium (0.03 to 0.04 mg/kg/h)
Number of subjects: 40
Study: 24215386

Group type: EXPERIMENTAL
Intervention: Implementation of at least three new nutrition practice changes and three new nutrition policies.
Number of subjects: 1176

Group type: EXPERIMENTAL
Intervention: Introduction of mostly healthful foods in competitive venues at lunch.
Number of subjects: 1176

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 1176